Treatment of advanced and recurrent gynecologic cancer.
Publication/Presentation Date
10-15-1987
Abstract
In 1986 73,400 new cases of invasive gynecologic cancer and 45,000 new cases of in situ carcinoma of the uterine cervix (about 9% of all cancers in women) were diagnosed in the US. A significant proportion of these patients die of local failure. In dealing with the wide variety of gynecologic cancers, extreme care must be used in choosing the appropriate treatment program for each problem. Therefore, the full extent of the disease at the time of initial presentation and recurrence must be determined. It is only with these data that appropriate treatment programs can be designed with the maximum potential for long-term control or cure and with the minimum in treatment complication. There are no groups of disease processes like those seen in advanced or recurrent gynecologic cancer that offer such a challenge to the clinical practitioner.
Volume
60
Issue
8 Suppl
First Page
2081
Last Page
2093
ISSN
0008-543X
Published In/Presented At
Brady, L. W., Markoe, A. M., DeEulis, T., & Lewis, G. C., Jr (1987). Treatment of advanced and recurrent gynecologic cancer. Cancer, 60(8 Suppl), 2081–2093. https://doi.org/10.1002/1097-0142(19901015)60:8+<2081::aid-cncr2820601522>3.0.co;2-n
Disciplines
Medicine and Health Sciences
PubMedID
3308068
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article